Price to tangible book value = 0.96 vs industry avg of 8.34
Price to Sales = 0.36 vs 1.25 IA
Dividend yield = 3.20% vs 1.90% IA
ESPR's P/B ratio = 2.90 vs. industry average of 20.37
He said now is a good time to buy TWTR
She said that the results of the Lentiglobin gene therapy treatment that apparently worked great in 6 of the 9 particcipants were great and thus she is perplexed why the stock went down 20% today.
I'm long at $71.50
Price os stock now at $25.75
Lowered earnings expectation for the year = $1.87 (midpoint of range)
New P/E = 13.8 vs. industry average of 24.1
I plan to buy some shares after I determine that a bottom has been hit, through technical analysis.